<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00778804</url>
  </required_header>
  <id_info>
    <org_study_id>4159</org_study_id>
    <nct_id>NCT00778804</nct_id>
  </id_info>
  <brief_title>Preventing Heart Disease in Underserved Patients</brief_title>
  <official_title>Preventing Heart Disease in Underserved Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Insight Telehealth Systems</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pennsylvania Department of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the impact of an internet based telemedicine system on cardiovascular
      risk profile of underserved patient populations. It is our hypothesis that a treatment plan
      and frequent communication via an internet based Telemedicine system will improve the
      cardiovascular risk profile of underserved patient populations at increased risk for
      cardiovascular disease. Our primary endpoint is a reduction over one year in the 10-year CVD
      risk score (ATP III risk model).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Insight Telehealth system (ITSMyHealthfile) is a disease-managment interactive health
      care delivery system. Patients access the system through a special Web site using a password.
      The system prompts the patient to enter their weight, blood pressure and heart rate and there
      is a text box available for unstructed comments.

      Patients will be randomized to either the telemedicine group or usual care group (controls).
      Individuals in the telemedicine group will be asked to transmit their health status weekly.
      Both groups will be followed for one year with quarterly visits.

      Patients of either sex, of any ethnic background or race, between 22 and 85years of age, who
      have a 10% or greater 10-year risk of CVD based on the Framingham risk score, and risk
      factors that if properly treated would reduced the risk by 5% or greater will be eligible for
      the study.

      Additional criteria

        -  literate

        -  telephone access

        -  ablility to utilize the Internet and telemedicine system (after training) Primary
           Outcome Reduction in Framingham risk index
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Framingham 10-year risk index</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure, cholesterol, 6 minute walk test, glucose and A1c, CVD knowledge and risk perception</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">465</enrollment>
  <condition>Hypertension</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>telemedicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Web-based monitoring in addition to usual clincial care with quarterly visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Ususal care with quarterly visits</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>telemedicine</intervention_name>
    <description>Weekly transmission of health status (weight, activity, BP etc.) via the Internet with feeedback and reinforcement</description>
    <arm_group_label>telemedicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Framingham risk score equal to or greater than 10%

          -  literacy

          -  22 -85 years of age

          -  access to phone

               -  ability to use Internet and system following training

        Exclusion Criteria:

          -  Class 3 and 4 heart failure

          -  ESRD

          -  stroke with residual disability or dementia

          -  unable to read or write
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfred A Bove, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hosptial</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2008</study_first_submitted>
  <study_first_submitted_qc>October 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2008</study_first_posted>
  <last_update_submitted>October 22, 2008</last_update_submitted>
  <last_update_submitted_qc>October 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2008</last_update_posted>
  <responsible_party>
    <name_title>Catherine Becker</name_title>
    <organization>Pennsylvania Department of Health</organization>
  </responsible_party>
  <keyword>CVD risk</keyword>
  <keyword>self monitoring</keyword>
  <keyword>Internet</keyword>
  <keyword>telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

